22/09/2005
Pursuant to the Companies Act 1985, ReGen Therapeutics Plc (the ‘Company’) has received notification on the 22 September 2005 from Wills & Co Stockbrokers Limited that it has a beneficial interest in 13,920,000 ordinary shares in the Company, registered in the name of Pershing Keen Nominees, representing approximately 3.21% of the current issued share capital.
For further information, please contact:
Andrew Marshal
Marshall Robinson Roe
Tel. No. 020 7960 6007